Oramed Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$3.44(as of Jan 21, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Oramed Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$3.44
Ticker SymbolORMP
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
EmployeesUnknown
CountyUSA
Market Cap$146.6M

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Oramed Pharmaceuticals Inc In Our Stock Scanner

As of Jan 21, 2026
As of ---
As of ---
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Low PE RatiosScan Type: Stock Fundamentals
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.